BCAXBicara Therapeutics Inc.

$24.70

Who owns BCAX

146 institutions reported holding BCAX for 2026Q1, together 117% of the company, more than the 140 a quarter earlier.

146

Institutions reporting a position · as of 2026Q1 · up from 140 the quarter before

Shares held by institutions
71.3M

Shares held by institutions · 117% of the company · long US equity positions only, as reported on Form 13F

Reported value
$1.40B

Reported value · at 2026-03-31 prices, not today's

Opened vs closed
24 / 24

Opened vs closed · new positions against positions exited in the latest quarter

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
7
New positions
24
Positions exited
24
Added to
55
Reduced
37
Institutional ownership by quarter, 2024Q3 to 2026Q1
QuarterFilersSharesReported value
2026Q114671.3M$1.40B
2025Q414058.4M$1.01B
2025Q311450.2M$789M
2025Q210651.2M$475M
2025Q19248.6M$634M
2024Q48446.7M$814M
2024Q36836.4M$928M
Largest reported holders, 2026Q1
HolderShares% of companyValue
RA CAPITAL MANAGEMENT, L.P.7.3Mn/a$144M
T. Rowe Price Investment Management, Inc.6.6Mn/a$131M
Siren, L.L.C.5.8Mn/a$115M
Vestal Point Capital, LP5.4Mn/a$108M
Deep Track Capital, LP4.1Mn/a$81M
HENDERSON GROUP PLC3.3Mn/a$66M
RED TREE MANAGEMENT, LLC3.2Mn/a$63M
TPG GP A, LLC3.0Mn/a$60M
BlackRock Inc.2.8Mn/a$57M
Omega Fund Management, LLC2.4Mn/a$48M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…